Virginia
Provider Communications
Clinical Criteria updates for specialty pharmacy are available
For Anthem Blue Cross and Blue Shield and our affiliate HealthKeepers, Inc., prior authorization of these specialty pharmacy drugs will be managed by Anthem. Drugs used for the treatment of Oncology will still require prior authorization by AIM Specialty Health®* (AIM). This applies to members with Preferred Provider Organization (PPO), Anthem HealthKeepers (HMO), POS AdvantageOne, and Act Wise (CDH plans).
Access the Clinical Criteria document information
ING-CC-0029 |
Dupixent (dupilumab) |
ING-CC-0035 |
Duopa (carbidopa and levodopa enteral suspension) |
ING-CC-0058 |
Byngezia Pen, Sandostatin, or Sandostatin LAR (Octreotide)/ Octreotide Agents |
ING-CC-0142 |
Somatuline Depot (lanreotide) |
ING-CC-0176 |
Beleodaq (belinostat) |
ING-CC-0188 |
Imcivree (setmelanotide) |
Featured In:
November 2022 Anthem Provider News - Virginia